Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study (Q73993241)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 July 2000
edit
Language Label Description Also known as
English
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study
scientific article published on 01 July 2000

    Statements

    Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit